ArticleNational journal of maxillofacial surgery
The outcomes of Facial Artery Musculomucosal (FAMM) flaps in oral oncologic reconstructions.
Article in National journal of maxillofacial surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Retraction: The outcomes of Facial Artery Musculomucosal (FAMM) flaps in oral oncologic reconstructions.National journal of maxillofacial surgeryArticle
Corrections and comments
- Retraction · 2025-08-30Concerns/Issues about Data · Conflict of Interest · Falsification/Fabrication of Data ·
- Retracted
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Head and neck cancer ablation results in challenging defects with complex reconstructive needs. The type of reconstruction depends on the nature, site, and size of the defect. Facial artery Musculomucosal (FAMM) flap reconstruction has emerged as a versatile option in a variety of small and medium-sized oral and oropharyngeal defects. We describe our experience reconstructing 12 intraoral defects with FAMM flap following resection for benign or malignant disease, with some having their surgery during the early Covid 19 pandemic. Materials and Methods: We examined patient demographics, diagnosis, site, TNM staging, type of FAMM flap, associated functional/cosmetic outcomes, oncological resection margins and adjuvant treatment. Results: Most patients (75%) had Squamous cell carcinoma, with the palate (41.6%) being the most common site. Inferiorly based FAMM flaps (91.7%) were used in the majority. Clinically, T1 and T2 tumours (91.7%) were the most common. 91.7% had resumed normal dietary function; 83.4% had fully intelligible speech as assessed by the speech and language therapist; and 91.7% had aesthetically pleasing outcomes. 81.8% had clear resection margins. Two patients developed small residual oroantral fistulae requiring repair. Conclusion: The FAMM flap is a reliable option for reconstructing small to medium-sized oral defects with several advantages and excellent functional and cosmetic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.